(Reuters) - Ampio Pharmaceuticals Inc said a mid-stage trial of its experimental drug to treat retinal swelling in diabetic patients was ended ahead of schedule based on positive interim data,...
Source: http://feeds.reuters.com/~r/reuters/globalmarketsNews/~3/ZGZa2U_Smyo/us-ampiopharmaceuticals-idUSBRE82I0M820120319
travel destinations top news world news domestic news summit news sports news
No comments:
Post a Comment